101 related articles for article (PubMed ID: 7761007)
1. Use of a neural network and a multiple regression model to predict histologic grade of astrocytoma from MRI appearances.
Christy PS; Tervonen O; Scheithauer BW; Forbes GS
Neuroradiology; 1995 Feb; 37(2):89-93. PubMed ID: 7761007
[TBL] [Abstract][Full Text] [Related]
2. Neural networks analysis of astrocytic gliomas from MRI appearances.
Abdolmaleki P; Mihara F; Masuda K; Buadu LD
Cancer Lett; 1997 Sep; 118(1):69-78. PubMed ID: 9310262
[TBL] [Abstract][Full Text] [Related]
3. Karyometric features of low and high grade glial tumors as compared with their MRI appearance.
Scarpelli M; Montironi R; Salvolini U; Messori A; Bartels PH
Anal Quant Cytol Histol; 2004 Apr; 26(2):87-96. PubMed ID: 15131896
[TBL] [Abstract][Full Text] [Related]
4. Potential Utility of Visually AcceSAble Rembrandt Images Assessment in Brain Astrocytoma Grading.
Yu J; Wang M; Song J; Huang D; Hong X
J Comput Assist Tomogr; 2016; 40(2):301-6. PubMed ID: 26978002
[TBL] [Abstract][Full Text] [Related]
5. Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status.
Hyare H; Rice L; Thust S; Nachev P; Jha A; Milic M; Brandner S; Rees J
Eur J Radiol; 2019 May; 114():120-127. PubMed ID: 31005161
[TBL] [Abstract][Full Text] [Related]
6. A new method to classify pathologic grades of astrocytomas based on magnetic resonance imaging appearances.
Zhao ZX; Lan K; Xiao JH; Zhang Y; Xu P; Jia L; He M
Neurol India; 2010; 58(5):685-90. PubMed ID: 21045488
[TBL] [Abstract][Full Text] [Related]
7. In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry.
Chen J; Huang SL; Li T; Chen XL
Neuroradiology; 2006 May; 48(5):312-8. PubMed ID: 16552583
[TBL] [Abstract][Full Text] [Related]
8. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.
Morana G; Piccardo A; Milanaccio C; Puntoni M; Nozza P; Cama A; Zefiro D; Cabria M; Rossi A; Garrè ML
J Nucl Med; 2014 May; 55(5):718-23. PubMed ID: 24652828
[TBL] [Abstract][Full Text] [Related]
9. Computer-assisted discrimination of glioblastomas.
Scarpelli M; Montironi R; Thompson D; Bartels PH
Anal Quant Cytol Histol; 1997 Oct; 19(5):369-75. PubMed ID: 9349896
[TBL] [Abstract][Full Text] [Related]
10. Diffuse "fibrillary" astrocytomas: correlation of MRI features with histopathologic parameters and tumor grade.
Tervonen O; Forbes G; Scheithauer BW; Dietz MJ
Neuroradiology; 1992; 34(3):173-8. PubMed ID: 1630604
[TBL] [Abstract][Full Text] [Related]
11. A modern reproducible method for the histologic grading of astrocytomas with statistical classification tools.
Röhrl N; Iglesias-Rozas JR; Weidl G
Anal Quant Cytol Histol; 2008 Feb; 30(1):33-8. PubMed ID: 18459585
[TBL] [Abstract][Full Text] [Related]
12. Differentiation between Solitary Cerebral Metastasis and Astrocytoma on the Basis of Subventricular Zone Involvement on Magnetic Resonance Imaging.
Wang R; Ma J; Niu G; Zheng J; Liu Z; Du Y; Yu B; Yang J
PLoS One; 2015; 10(7):e0133480. PubMed ID: 26197398
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.
Zhang K; Li C; Liu Y; Li L; Ma X; Meng X; Feng D
Neuroradiology; 2007 Nov; 49(11):913-9. PubMed ID: 17763847
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.
You SH; Choi SH; Kim TM; Park CK; Park SH; Won JK; Kim IH; Lee ST; Choi HJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Radiology; 2018 Mar; 286(3):981-991. PubMed ID: 29244617
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma].
Chen J; Xia J; Zhou YC; Xia LM; Zhu WZ; Zou ML; Feng DY; Wang CY
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):309-11. PubMed ID: 15996330
[TBL] [Abstract][Full Text] [Related]
16. Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas.
Morita N; Wang S; Chawla S; Poptani H; Melhem ER
J Magn Reson Imaging; 2010 Oct; 32(4):803-8. PubMed ID: 20882610
[TBL] [Abstract][Full Text] [Related]
17. Prediction of posterior fossa tumor type in children by means of magnetic resonance image properties, spectroscopy, and neural networks.
Arle JE; Morriss C; Wang ZJ; Zimmerman RA; Phillips PG; Sutton LN
J Neurosurg; 1997 May; 86(5):755-61. PubMed ID: 9126888
[TBL] [Abstract][Full Text] [Related]
18. Regression of grade III astrocytoma during the treatment of CML with imatinib mesylate.
Jayawardena S; Sooriabalan D; Indulkar S; Kim HH; Matin A; Maini A
Am J Ther; 2006; 13(5):458-9. PubMed ID: 16988542
[TBL] [Abstract][Full Text] [Related]
19. Microvascular permeability of brain astrocytoma with contrast-enhanced magnetic resonance imaging: correlation analysis with histopathologic grade.
Jia ZZ; Geng DY; Liu Y; Chen XR; Zhang J
Chin Med J (Engl); 2013; 126(10):1953-6. PubMed ID: 23673117
[TBL] [Abstract][Full Text] [Related]
20. PET Imaging of cerebral astrocytoma with 13N-ammonia.
Xiangsong Z; Changhong L; Weian C; Dong Z
J Neurooncol; 2006 Jun; 78(2):145-51. PubMed ID: 16739028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
